Jorge Emilio Ortega

Jorge Emilio Ortega

Auto-generated profile, based on publicly available information

Jorge Emilio Ortega

Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Biological Psychiatry
Verified
Journal Article
Closed access
CACristina Alba-Delgado
Cristina Alba-Delgado
MLMeritxell Llorca-Torralba
Meritxell Llorca-Torralba
IHIgor Horrillo
Igor Horrillo
JOJorge E. Ortega
Jorge E. Ortega
JMJuan Antonio Mico
Juan Antonio Mico
EBEsther Berrocoso
Esther Berrocoso

1 April 2012 in Neuropharmacology
Verified
Journal Article
Closed access
EMEva Martisova
Eva Martisova
MSMaite Solas
Maite Solas
IHIgor Horrillo
Igor Horrillo
JOJorge E. Ortega
Jorge E. Ortega
JMJ Javier Meana
J Javier Meana
Maria Javier RamirezMaria Javier Ramirez
Maria Javier Ramirez

29 August 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
IEI. Erkizia-Santamaría
I. Erkizia-Santamaría
RAR. Alles-Pascual
R. Alles-Pascual
IHI. Horrillo
I. Horrillo
JMJ.J. Meana
J.J. Meana
JOJ.E. Ortega
J.E. Ortega
The psychedelic 5-HT2A receptor (5HT2AR) agonist psilocybin (or the active metabolite psilocin) has emerged as potential useful drug for various neuropsychiatric diseases, with a rapid onset of therapeutic activity. However, the mechanisms responsible for such effects remain incompletely characterized. We aimed to study in vitro pharmacological profile and in vivo acute mechanism of psilocin/psilocybin. Competition binding studies with psilocin were performed in brain and cell cultures. The role of 5HT2AR, 5-HT2C receptors (5HT2CR) and 5-HT1A receptors (5HT1AR) on the psychosis-like head-twitch response (HTR) and on body temperature in mice after psilocybin administration were evaluated. Psilocin showed similar affinities for 5HT2AR (Ki: 120-173 nM), 5HT2CR (Ki: 79-311 nM) and 5-HT1AR (Ki: 152-146 nM) in human and mice brain. Psilocybin induced a dose-dependent HTR (maximal effect 17.07 ± 1.31 at 1 mg/kg i.p.) that was completely suppressed by the 5HT2AR antagonist MDL11939 (1 mg/kg). Higher doses of psilocybin (3 mg/kg) induced lower HTR (9.00 ± 0.53). The 5HT2CR antagonist SB242084 (0.1 mg/kg) increased HTR exerted by psilocybin (3 mg/kg). Psilocybin significantly raised core body temperature at low dose (0.125 mg/kg) (Emax=0.67 ± 0.15 °C), whereas a significant decrease was induced by doses over 1 mg/kg (Emax = -1.31 ± 0.16 °C). Pre-treatment with the 5HT1AR antagonist WAY100635 reversed the decrease of body temperature after psilocybin (1 mg/kg), causing hyperthermia (Emax = 0.94 ± 0.26 °C). The present work provides key findings on the 5HT2AR, 5-HT2CR and 5HT1AR involvement in the acute central effects of psilocybin. The results may be relevant for understanding the mechanism of action underlying the therapeutic effects and side effects of this psychedelic drug.

18 October 2024 in Science Advances
Verified
Journal Article
Open access
CACarlos G. Ardanaz
Carlos G. Ardanaz
ACAida de la Cruz
Aida de la Cruz
PMParas S. Minhas
Paras S. Minhas
NHNira Hernández-Martín
Nira Hernández-Martín
MPMiguel A Pozo
Miguel A Pozo
MSMaite Solas
Maite Solas
Astrocytes are considered an essential source of blood-borne glucose or its metabolites to neurons. Nonetheless, the necessity of the main astrocyte glucose transporter, i.e., GLUT1, for brain glucose metabolism has not been defined. Unexpectedly, we found that brain glucose metabolism was paradoxically augmented in mice with astrocytic GLUT1 reduction (GLUT1 ΔGFAP mice). These mice also exhibited improved peripheral glucose metabolism especially in obesity, rendering them metabolically healthier. Mechanistically, we observed that GLUT1-deficient astrocytes exhibited increased insulin receptor–dependent ATP release, and that both astrocyte insulin signaling and brain purinergic signaling are essential for improved brain function and systemic glucose metabolism. Collectively, we demonstrate that astrocytic GLUT1 is central to the regulation of brain energetics, yet its depletion triggers a reprogramming of brain metabolism sufficient to sustain energy requirements, peripheral glucose homeostasis, and cognitive function.

29 October 2011 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
CACristina Alba-Delgado
Cristina Alba-Delgado
GBGisela Borges
Gisela Borges
PSPilar Sánchez-Blázquez
Pilar Sánchez-Blázquez
JOJorge E. Ortega
Jorge E. Ortega
IHIgor Horrillo
Igor Horrillo
EBEsther Berrocoso
Esther Berrocoso

7 May 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FRFernando Rodriguez
Fernando Rodriguez
IRIsabel Rozas
Isabel Rozas
JOJorge E. Ortega
Jorge E. Ortega
AEAmaia M Erdozain
Amaia M Erdozain
JMJ Javier Meana
J Javier Meana
LCLuis Callado
Luis Callado